Cargando…

The preventive effect on respiratory tract infections of Oscillococcinum(®). A cost-effectiveness analysis

BACKGROUND: Anas barbariae hepatis et cordis extractum 200K (Oscillococcinum(®)) is used to treat and prevent seasonal colds and airway inflammatory affections, improve symptom control, and reduce the frequency of respiratory tract infection (RTI) episodes. The objective of this controlled observati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colombo, Giorgio L, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Bruno, Giacomo M, Beghi, Gianfranco M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788925/ https://www.ncbi.nlm.nih.gov/pubmed/29416364 http://dx.doi.org/10.2147/CEOR.S144300

Ejemplares similares

Oscillococcinum(®) for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS)
por: Aouina, Hichem, et al.
Publicado: (2021)

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
por: Torre, Enrico, et al.
Publicado: (2018)

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2019)

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study
por: Canonica, Giorgio Walter, et al.
Publicado: (2020)

Does homeopathic medicine have a preventive effect on respiratory tract infections? A real life observational study
por: Beghi, Gianfranco Maria, et al.
Publicado: (2016)

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II
por: Torre, Enrico, et al.
Publicado: (2020)

Cost-effectiveness of gargling for the prevention of upper respiratory tract infections
por: Sakai, Michi, et al.
Publicado: (2008)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
por: Colombo, Giorgio L, et al.
Publicado: (2018)

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
por: Torre, Enrico, et al.
Publicado: (2020)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry
por: Canonica, Giorgio Walter, et al.
Publicado: (2019)

Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
por: Torre, Enrico, et al.
Publicado: (2022)

Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
por: Colombo, Giorgio L, et al.
Publicado: (2008)

Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation
por: Maggiolo, Franco, et al.
Publicado: (2015)

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus
por: Torre, Enrico, et al.
Publicado: (2021)

Syringeless power injector versus dual-syringe power injector: economic evaluation of user performance, the impact on contrast enhanced computed tomography (CECT) workflow exams, and hospital costs
por: Colombo, Giorgio L, et al.
Publicado: (2013)

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2011)

The Effect of Probiotics for Preventing Acute Upper Respiratory Tract Infections
por: Sæterdal, Ingvil, et al.
Publicado: (2012)

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
por: Colombo, Giorgio L, et al.
Publicado: (2011)

Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy
por: Poli, Anna, et al.
Publicado: (2015)

Frequency, Etiology, Mortality, Cost, and Prevention of Respiratory Tract Infections—Prospective, One Center Study
por: Duszynska, Wieslawa, et al.
Publicado: (2022)

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
por: Rizzardini, Giuliano, et al.
Publicado: (2012)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Effectiveness of Maternal Vitamin D Supplementation in Preventing Respiratory Tract Infections in Children
por: Kim, Soo Young
Publicado: (2022)

Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art
por: De Benedetto, Fernando, et al.
Publicado: (2013)

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
por: Colombo, Giorgio L, et al.
Publicado: (2013)

Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers
por: Berber, Arturo, et al.
Publicado: (2019)

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A
por: Colombo, Giorgio L, et al.
Publicado: (2011)

Probiotics and Prebiotics for Prevention of Viral Respiratory Tract Infections
por: Ahanchian, Hamid, et al.
Publicado: (2016)

SARS coronavirus infections of the lower respiratory tract and their prevention
por: Petrovsky, N.
Publicado: (2016)

Probiotic Therapy With VSL#3(®) in Patients With NAFLD: A Randomized Clinical Trial
por: Derosa, Giuseppe, et al.
Publicado: (2022)

Cost-Effectiveness of Point-of-Care C-Reactive Protein Tests for Respiratory Tract Infection in Primary Care in England
por: Hunter, Rachael
Publicado: (2015)

Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2023)

The cost of lower respiratory tract infections hospital admissions in the Canadian Arctic
por: Banerji, Anna, et al.
Publicado: (2013)

Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy
por: Ruggeri, Isabella, et al.
Publicado: (2012)

Cost-Effective Respiratory Virus Testing
por: Pinsky, B. A., et al.
Publicado: (2019)

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
por: Colombo, Giorgio L, et al.
Publicado: (2009)

A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children
por: Mas-Dalmau, Gemma, et al.
Publicado: (2023)

Cost-Effectiveness of Cranberries vs Antibiotics to Prevent Urinary Tract Infections in Premenopausal Women: A Randomized Clinical Trial
por: Bosmans, Judith E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mmlv4kr3q4qel8ecuv0bfhmst8